Rapid Tests and Point of Care Market to 2017 – Clinical Chemistry Tests to be the Major Revenue Generator

Publisher Name :
Date: 1-Feb-2013
No. of pages: 76

This research provides key data, information and analysis on the global rapid tests and point of care (POC) market. The report provides information on the market landscape, the competitive landscape and market trend information on three rapid tests and POC market categories: clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests. The report provides comprehensive information on the key trends affecting these categories and key analytical content on the market’s dynamics. The report also provides profiles of the major companies operating in the rapid tests and POC market and a detailed analysis of the pipeline products in each category. Furthermore, the report reviews the details of important merger and acquisition deals that have taken place in the rapid tests and POC market over the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • The market size of three rapid tests and POC market categories – clinical chemistry rapid tests and POC, immunochemistry rapid tests, and hematology rapid tests.
  • Annualized market revenue data from 2003 to 2010, forecast forward for 7 years to 2017.
  • Qualitative analysis of key market trends, market drivers and restraints of each category within the rapid tests and POC market.
  • The report also covers information on the leading players in the market and the leading technologies.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments that are driving the global rapid tests and POC market.
  • Design and develop your product’s development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market the players with the most innovative pipeline.
  • Develop market entry and market expansion strategies.
  • Identify the key players best positioned to take advantage of emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • What’s the next big thing in the rapid tests and POC market landscape? Identify, understand and capitalize.
  • Make more informed business decisions with the aid of insightful and in-depth analysis of the global rapid tests and POC market and the factors shaping it.

Rapid Tests and Point of Care Market to 2017 – Clinical Chemistry Tests to be the Major Revenue Generator

1 Table Of Contents

1.1 List of Tables
1.2 List of Figures

2 Executive Summary

2.1 Rapid Tests and Point of Care Market Forecast to Increase at a CAGR of 7% During the Period 2010–2017
2.2 Significant Consolidation in Recent Years to Reshape the Competitive Landscape in the Industry
2.3 Clinical Chemistry Rapid Tests and POC to Continue to be the Largest Segment in the Global Rapid Tests and Point of Care Market

3 Introduction

3.1 GBI Research Guidance

4 Global Rapid Tests and Point of Care Market: Market Characterization

4.1 Global Rapid Tests and Point of Care Market, Revenue ($m), 2003 – 2010
4.2 Global Rapid Tests and Point of Care Market, Revenue ($m), 2010 – 2017
4.3 Global Rapid Tests and Point of Care Market, Key Market Trends
4.3.1 Decentralization of Laboratories is a Growing Trend Across the World
4.3.2 Integration of POC Devices with Hospital Information Systems is a Growing Trend
4.3.3 Significant Consolidation in Recent Years to Reshape the Competitive Landscape of the Industry
4.3.4 Increased Demand for Rapid Tests and POC Testing in Emerging Countries Will Drive the Growth of the Market in the Near Future
4.4 Global Rapid Tests and Point of Care, Market Dynamics
4.4.1 Global Rapid Tests and Point of Care, Market Drivers
4.4.1.1 Continuing Improvements in Rapid Tests and POC Testing to Drive Market Growth
4.4.1.2 Advantages of Rapid Tests and POC Testing Over Traditional Laboratory Testing are Driving Market Growth
4.4.1.3 Expanded Menu of Point of Care Tests Will Result in Increased Usage of POC Testing, Leading to the Growth of the POC Tests and Rapid Tests Market
4.4.1.4 Increasing Prevalence of Infectious Diseases to Drive the Rapid Tests and POC Market Globally
4.4.2 Global Rapid Tests and Point of Care, Market Restraints
4.4.2.1 Pricing Pressures to Adversely Affect the Revenues of the Rapid Test and POC Test Industry
4.4.2.2 High Per Test Cost of Rapid Tests and POC Tests to Hinder Market Growth
4.4.2.3 Drawbacks Associated with POC Devices to Hinder Adoption Significantly
4.4.2.4 Complexity of Data Management and Error Management to Hinder Market Growth

5 Global Rapid Tests and Point of Care Market: Market Category Analysis and Forecasts

5.1 Clinical Chemistry Rapid Tests and POC
5.1.1 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010
5.1.2 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue Forecasts ($m), 2010–2017
5.2 Clinical Chemistry Rapid Tests and POC Market: Market Dynamics
5.2.1 Clinical Chemistry Rapid Tests and POC Market: Market Drivers
5.2.1.1 Increase in Percentage of Population Seeking Critical Care Will Drive the Clinical Chemistry Rapid Tests and POC Tests Market
5.2.1.2 Technological Advancements to Drive the Clinical Chemistry Rapid Tests and POC Tests Market
5.2.2 Clinical Chemistry Rapid Tests and POC Market: Market Restraints
5.2.2.1 Poor Sensitivity and Poor Specificity of Test Strips for Some Analytes to Slow Down Market Growth
5.3 Immunochemistry Rapid Tests Market
5.3.1 Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 – 2010
5.3.2 Immunochemistry Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 – 2017 31
5.4 Immunochemistry Rapid Tests Market: Market Dynamics
5.4.1 Immunochemistry Rapid Tests Market: Market Drivers
5.4.1.1 Lateral Flow Assays to Drive the Immunochemistry Rapid Tests Market
5.4.1.2 Technological Advancements Such as Microfluidics in Rapid Immunoassays to Drive Market Growth
5.4.1.3 Wide Range of Immunoassay Applications to Drive the Immunochemistry Rapid Tests Market
5.4.2 Immunochemistry Rapid Tests Market: Market Restraints
5.4.2.1 Limitations Such as Low Sensitivity of Immuno Assays to Hinder Market Growth
5.5 Hematology Rapid Tests Market
5.5.1 Hematology Rapid Tests Market, Global, Revenue ($m), 2003 – 2010
5.5.2 Hematology Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 – 2017
5.6 Hematology Rapid Tests Market: Market Dynamics
5.6.1 Hematology Rapid Tests Market: Market Drivers
5.6.1.1 Availability of Innovative Rapid Test Devices to Drive Market Growth
5.6.1.2 Blood Spot Tests to Drive the Growth of the Hematology Rapid Tests Market
5.6.2 Hematology Rapid Tests Market: Market Restraints
5.6.2.1 Limitations Such as Low Target Sensitivity and Small Volume of Dried Blood Spots to Slow Down Adoption Rates in the Near Future

6 Global Rapid Tests and Point of Care Market: Country Analysis and Forecasts

6.1 Rapid Tests and Point of Care Market: Cross–Country Analysis
6.2 Revenue Forecasts, by Country, 2003 – 2017
6.2.1 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 – 2010
6.2.2 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 – 2017
6.2.3 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 – 2010
6.2.4 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 – 2017
6.2.5 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 – 2010
6.2.6 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 – 2017
6.2.7 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010
6.2.8 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010–2017
6.2.9 Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010
6.2.10 Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017
6.2.11 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010
6.2.12 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017
6.2.13 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010
6.2.14 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017
6.2.15 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010
6.2.16 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017
6.2.17 Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010
6.2.18 Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017
6.2.19 Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010
6.2.20 Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017
6.2.21 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010
6.2.22 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017
6.2.23 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003–2010
6.2.24 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017

7 Global Rapid Tests and Point of Care Market: Key Market Participants

7.1 F. Hoffmann–La Roche Ltd.
7.1.1 Business Overview
7.1.2 Marketed Products
7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Marketed products
7.3 Siemens Healthcare (Subsidiary of Siemens AG)
7.3.1 Business Overview
7.3.2 Marketed Products
7.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
7.4.1 Business Overview
7.4.2 Marketed Products:
7.5 bioMerieux S.A. (Subsidiary of Merieux Alliance Group)
7.5.1 Business Overview
7.5.2 Marketed products
7.6 DiaSorin S.p.A
7.6.1 Business Overview
7.6.2 Marketed Products:

8 Global Rapid Tests and Point of Care Market: Product Pipeline Analysis

8.1 Rapid Tests and Point of Care Market: Pipeline Product Summary
8.2 Rapid Tests and Point of Care Market: List of Pipeline Products
8.3 Rapid Tests and Point of Care: Profiles of Key Pipeline Products
8.3.1 ImmProCon Technology
8.3.2 RAPIDPoint 500 System – Lactate Assay
8.3.3 Sali–Chek Reader
8.3.4 Point Of Care Diagnostic Device
8.3.5 ACE Alera Clinical Chemistry System – Direct A1c Assay
8.3.6 Advia 120 Hematology System – IRF Test
8.3.7 AIA–600 II – D–dimer Test

9 Global Rapid Tests and Point of Care Market: Consolidation Landscape

9.1 Rapid Tests and Point of Care Market: Key Deals 2011
9.1.1 Sony Corporation of America Acquires Micronics
9.1.2 Roche Completes Acquisition of MTM Laboratories
9.1.3 Quest Diagnostics Completes Acquisition of Athena Diagnostics
9.1.4 Danaher Completes Acquisition of Beckman Coulter
9.2 Rapid Tests and Point of Care Market: Key Deals, 2007–2010
9.2.1 Merck Completes Acquisition of Millipore
9.2.2 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics
9.2.3 Inverness Medical Innovations Completes Acquisition of Concateno from Marwyn
9.2.4 bioMerieux Acquires AviaraDx
9.2.5 Siemens Medical Acquires Dade Behring
9.2.6 Roche Acquires Ventana Medical Systems
9.2.7 Bio–Rad Laboratories Acquires Diamed

10 Appendix

10.1 Definitions
10.1.1 Clinical Chemistry Rapid Tests & POC
10.1.2 Immunochemistry Rapid Tests Market
10.1.3 Haematology Rapid Tests Market
10.2 Sources
10.3 Acronyms
10.4 Research Methodology
10.4.1 Secondary Research
10.4.2 Primary Research
10.4.3 Models
10.4.4 Forecasts
10.4.5 Expert Panels
10.5 Contact Us
10.6 Disclaimer

List of Tables

Table 1 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003–2010
Table 2 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010–2017
Table 3 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010
Table 4 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010–2017
Table 5 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010
Table 6 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017
Table 7 : Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010
Table 8 : Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017
Table 9 : Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003–2017
Table 10 : Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003–2010
Table 11 : Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010–2017
Table 12 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003–2010
Table 13 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010–2017
Table 14 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003–2010
Table 15 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010–2017
Table 16 : Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010
Table 17 : Rapid Tests and Point of Care Market, the Germany, Revenue ($m), 2010–2017
Table 18 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010
Table 19 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017
Table 20 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010
Table 21 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017
Table 22 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010
Table 23 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017
Table 24 : Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010
Table 25 : Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017
Table 26 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010
Table 27 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017
Table 28 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010
Table 29 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017
Table 30 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010
Table 31 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017
Table 32 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010
Table 33 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017
Table 34 : Rapid Tests and Point of Care Market, Global, Pipeline Product Summary, 2010
Table 35 : Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage
Table 36 : Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010–11
Table 37 : Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010–12
Table 38 : ImmProCon Technology, Product Status, 2011
Table 39 : RAPIDPoint 500 System, Product Status, 2011
Table 40 : Sali–Chek Reader, Product Status, 2011
Table 41 : Point Of Care Diagnostic Device, Product Status, 2011
Table 42 : ACE Alera Clinical Chemistry System – Direct A1c Assay, Product Status, 2011
Table 43 : Advia 120 Hematology System – IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011
Table 44 : Advia 2120 Hematology System – MPC (Mean Platelet Component) Test, Product Status, 2011
Table 45 : AIA (Automated Immunoassay Analyzer)–600 II – D–dimer Test, Product Status, 2011

List of Figures

Figure 1 : Rapid Tests and Point of Care Market, Global, Revenue ($bn), 2010–2017
Figure 2 : Clinical Chemistry Rapid Tests and POC, Global, Segment–Wise Revenue, ($m), 2010
Figure 3 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003–2010
Figure 4 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010–2017
Figure 5 : Rapid Tests and Point of Care Market, Market Categorization and Segmentation
Figure 6 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010
Figure 7 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010–2017
Figure 8 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010
Figure 9 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017
Figure 10 : Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010
Figure 11 : Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017
Figure 12 : Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003–2017
Figure 13 : Tests and Point of Care Market, the US, Revenue ($m), 2003–2010
Figure 14 : Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010–2017
Figure 15 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003–2010
Figure 16 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010–2017
Figure 17 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003–2010
Figure 18 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010–2017
Figure 19 : Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010
Figure 20 : Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010–2017
Figure 21 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010
Figure 22 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017
Figure 23 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010
Figure 24 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017
Figure 25 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010
Figure 26 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017
Figure 27 : Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010
Figure 28 : Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017
Figure 29 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010
Figure 30 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017
Figure 31 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010
Figure 32 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017
Figure 33 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010
Figure 34 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017
Figure 35 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010
Figure 36 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017
Figure 37 : Rapid Tests and Point of Care Market, Global, Pipeline Product Summary (%), 2010
Figure 38 : Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage

  • Most Effective Treatments For Diabetes
    Diabetes is a chronic metabolic disease leading to high blood sugar because or troubled insulin secretion. There are two types of diabetes – type 1 and type 2. Type 1 or juvenile diabetes causes when the body fails to produce enough insulin. Type 2 on the other hand causes when the body cells have lower [...]
  • Importance of Educational Books Publishing
    Education plays a crucial role in overall development of a person and the entire society. Students across the globe and various educational levels depend on study material. Whether they are textbooks, reference books or workbooks, they are in a constant need for systematic educational books. Educational book publishing is a versatile crucial branch of book [...]
  • How to Treat Arthritis Effectively ?
    The word arthritis stands for inflammation of joints. It is an umbrella term for over 100 diseases that cause pain, discomfort, disability and several other symptoms amongst individuals. Osteoarthritis is one of the most common types of arthritis, which affects elderly. Several other forms of this disease may affect individuals at a very young age [...]
  • Benefits of Set top Boxes Amidst the Wave of Digitization
    A set top unit or box is a useful device that provides content through television sets. Set top box is a term that refers to a device, which is used for broadcasting the content. It is different from the devices that help simple recording of media, such as DVDs. Cable operators and satellite companies provide [...]
  • What are the Treatments for Alzheimer’s Disease ?
    Alzheimer’s disease is one of the most common types of dementia. Dementia is the condition defined by significant loss of global cognitive ability in a healthy person. This loss is beyond the normal aging process and it only worsens with the age. Alzheimer’s disease is a serious mental health condition and a progressive brain disease [...]
  • Foresight 2020: Network Development in a Multi-Channel World
  • London, May 24th, 2013 – As the costs of branch banking increased in the 80s and 90s, banks attempted to reduce costs by reliance on centers, mobile and online channels to lower costs and improve service. The digitization of banks …

  • Italy Healthcare Industry Regulatory and Reimbursement Landscape
  • The Italian Pharmaceutical Market has Declined in Value Terms Due to the Introduction of Price Cuts and Increasing Focus on the Usage of Generic Drugs in Order to Rein in Ballooning Healthcare Expenditure   The pharmaceutical market (at the consumer …

  • Men’s Health & Midlife Women Consumer Market Research Reports
  • RnRMarketResearch.com offers new market research reports on masculinity Vs health and midlife women embracing power and avoiding invisibility in global consumer markets.   “Masculinity Vs Health: Challenges and Opportunities” and “Midlife Women: Embracing Power and Avoiding Invisibility in Global Consumer …

  • France Healthcare Market Regulatory and Reimbursement Landscape
  • France has a Mature Healthcare Market as it Offers Universal Public Access to Healthcare Facilities and Insurance. The Increasing Disease Burden and the Launch of New Products will Drive the Growth of the Pharmaceutical Market; however, Increasing Focus on Generics …

  • Lebanon Cards and Payments Industry Worth 2.4 Million Cards By 2017
  • Between 2008 and 2012, Lebanon’s cards industry recorded a CAGR of 4.89% in terms of volume and the total number of cards increased from 1.6 million to 2.0 million. The industry has been forecasted to grow at a CAGR of …

  • POC Lipid Testing Market: US, Germany, Spain–Physician Offices, Emergency Rooms, Ambulatory Care Centers
    "......ble suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Rationale The growing economic pressures on hospitals, coupled with advanc......"
  • Drugs of Abuse: A Analysis of the Point-of-Care Testing Market: US, Germany, Spain, Physician Offices, Emergency Rooms, Ambulatory Care Centers
    "......rument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market. Rationale The growing economic pressures on hospitals, coup......"
  • 2013 Analysis of the Point-of-Care Infectious Disease Diagnostics Market: US, Germany, Spain Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers
    "......t and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. Rationale The growing economic pressures on hosp......"
  • 2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,–Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
    "...... and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. Rationale The growing economic pressures on hospitals, coupled wi......"
  • 2013 Analysis of the Point-of-Care Coagulation Testing Market: US, Germany, Spain Physician Offices, Emergency Rooms, Operating Suites, ICUs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
    "......ent and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. Rationale The growing economic pressures on hospitals, coupled ......"